Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas

J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu et al. · JNCI Journal of the National Cancer Institute · 1998 · 1.6K citations · Full text

Medicine, Molecular Genetics, Oncology +13

Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas

Justin S. Smith, Arie Perry, Thomas J. Borell et al. · Journal of Clinical Oncology · 2000 · 806 citations

Medicine, Neurology, Oncology +16

A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

Robert B. Jenkins, Hilary Blair, Karla V. Ballman et al. · Cancer Research · 2006 · 759 citations · Full text

Medicine, Cancer Biology, Oncology +13

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin J. van den Bent, Alba A. Brandes, Marc Sanson et al. · Journal of Clinical Oncology · 2006 · 744 citations

Medicine, Oncology, Radiation Oncology +17

Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402

Gregory Cairncross, Brian Berkey, Edward Shaw et al. · Journal of Clinical Oncology · 2006 · 725 citations

Medicine, Oncology, Surgery +15